Delivery Order SPE2DB25D7056-SPE2DB25FTMTY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,097.68 on April 30, 2025, for the supply of Advair 250-50 Diskus 60 count inhalers, with completion scheduled for May 1, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Advair 115 mcg 12 gm inhalers valued at $8,477.56 under a firm fixed-price contract type. The award was made on August 6, 2025, with an ultimate completion date of August 7, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing contract vehicle. The product will be performed at the vendor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency (DLA) awarded a $5,115.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADVAIR 250-50 DISKUS 60S, a combination inhalant medication used to treat asthma and chronic obstructive pulmonary disease. The award, issued on June 2, 2025, with completion targeted for June 3, 2025, represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the agency. This non-set-aside, competitively awarded contract will...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,552.67 delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhaler (12 grams) on September 10, 2025, with completion expected by September 11, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's existing pharmaceutical supply agreements with the federal government. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,911.44 to AmerisourceBergen Drug Corp for Advair 500-50 Diskus 60s pharmaceutical product, with an ultimate completion date of August 18, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency awarded a $2,965.10 delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed openly among qualified vendors. This delivery...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMTYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,064.60 to AmerisourceBergen Drug Corp for the supply of Advair 250-50 Diskus 60s, a combination inhaler medication used in respiratory therapy. The contract, effective July 14, 2025, with an ultimate completion date of July 15, 2025, carries a firm fixed price structure with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical supplies across multiple therapeutic domains, with DLA Troop Support planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/14/25 |